Skip to main content
SpringerLink
Log in

ESSENCE

sweet smell of success lingers at 1-year follow-up

  • Newsletter Article
  • Published:
PharmacoEconomics & Outcomes News Weekly

Abstract

T he low molecular weight heparin enoxaparin sodium remains more effective than unfractionated heparin up to a year after treatment in patients with unstable angina pectoris or non-Q wave myocardial infarction, according to new results from the ESSENCE study announced during the 47th Annual Scientific Sessions of the American College of Cardiology [ Atlanta, US; March 1998 ]. Meanwhile, a re-analysis of the original ESSENCE data highlighted marked variations in practice between countries even within the confines of a clinical trial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Mark Greener
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greener, M. ESSENCE. Pharmacoecon. Outcomes News 162, 3–4 (1998). https://doi.org/10.1007/BF03284860

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03284860

Keywords

Search

Navigation